INSIGHTS ON DRUG DEVELOPMENT
-
Little Patients, Big Challenges: Developing Pediatric Formulations
Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.
-
Cell Cycle Mapping In Tumors With Advanced Technologies
Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.
-
How To Confidently Predict Toxicity Of Preclinical Drug Candidates
Incorporating Liver-Chips into preclinical workflows could reduce drug-induced liver injury-related trial failures. Review this quantitative framework for integrating Liver-Chip data into pharmaceutical decision-making.
-
A Patented Process For Intermediates Useful For Upadacitinib
Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.
-
Measuring Thermodynamic Parameters In The Drug Development Process4/29/2025
Join Dr. Ladbury to explore how thermodynamic data can enhance our understanding of protein-ligand interactions and how it is crucial for optimizing drug efficacy and safety in pharmaceutical development.
-
Expanding Translational Research Concepts With Genedata Profiler11/26/2024
The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.
-
Calcium Carbonate Vs Titanium Dioxide: Why Particle Engineering Matter11/10/2025
Discover how particle-engineered calcium carbonate offers a viable alternative to titanium dioxide in tablet coatings, achieving good opacity, process efficiency, and comparable tablet properties.
-
Process Intensification: Your Guide To "Doing More With Less"8/5/2025
Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.
-
Five Practical Considerations To Move From Concept To Clinic12/17/2025
Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
DRUG DEVELOPMENT SOLUTIONS
-
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
We have developed an innovative portfolio of affinity chromatography resins to help you solve challenges in the downstream process of next-generation antibody therapeutics. These resins are specifically designed for the purification of engineered monoclonal antibody (mAbs) modalities.
-
Uniquely Ergonomic System Microscope Leica DM1000
The ergonomically designed Leica DM1000 with adjustable features and easy-to-use controls adapts to every user to improve comfort and convenience while working at the microscope.
Featuring high-quality optical performance, the Leica DM1000 is ideal for all clinical laboratory applications, in particular cytology, haematology, and pathology. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
Its advanced capabilities, including fluorescence, make it well suited also for complex tasks.
-
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
Our comprehensive network of manufacturing facilities enables us to offer robust supply assurance and consistent product quality to biopharmaceutical developers around the globe.